-
公开(公告)号:JP2004189740A
公开(公告)日:2004-07-08
申请号:JP2003408899
申请日:2003-12-08
Inventor: OHASHI YUKIHIRO , FUJIMORI TAKETOSHI , KAWAMATA AKIRA , YADA YUKIHIRO , HIGUCHI KAZUHIKO , TAKEMA YOSHINORI , FUJIMURA TSUTOMU , IMOKAWA GENJI
IPC: A61K8/30 , A61K8/02 , A61K8/06 , A61K8/40 , A61K8/41 , A61K8/44 , A61K8/55 , A61K8/58 , A61K8/60 , A61K7/00
Abstract: PROBLEM TO BE SOLVED: To provide an external preparation for skin, having an excellent effect of preventing/improving wrinkles, making the skin maintain its normal function, and excellent in a dandruff-resisting effect and an effect of improving the skin after sunburned.
SOLUTION: This external preparation for skin contains an amine derivative expressed by general formula (1) (R
1 is a 1-40C hydrocarbon radical which may contain one or more hetero atoms; R
2 and R
3 are each a 1-3C bivalent hydrocarbon radical; R
4 is H or a 1-3C hydrocarbon radical; R
5 is H, a 1-3C hydrocarbon radical or -P(O)(OH)
2 ; R
6 is H or a 1-3C hydrocarbon radical which may have one or more hydroxy group; and Y is a 1-10C hydrocarbon radical which has one or more radicals, such as hydroxy group, alkoxy group, phosphate and carboxyl group) or general formula (2) (R
7 and R
8 are each a 1-3C hydrocarbon radical which may have one to three hydroxy groups).
COPYRIGHT: (C)2004,JPO&NCIPI-
公开(公告)号:JP2000007631A
公开(公告)日:2000-01-11
申请号:JP8168599
申请日:1999-03-25
Applicant: KAO CORP
Inventor: FUJIMORI TAKETOSHI , YAMAMURO AKIRA , FUJIKURA YOSHIAKI , HIGUCHI KAZUHIKO , HORI KIMIHIKO , IMOKAWA GENJI
IPC: A61K8/30 , A61K8/00 , A61K8/41 , A61K8/42 , A61K31/16 , A61P17/00 , A61Q19/00 , C07C217/28 , C07C233/18 , A61K7/00 , A61K7/48
Abstract: PROBLEM TO BE SOLVED: To obtain a new amido derivative having an excellent improving effect on a trouble caused by dyskeratosis of the skin. SOLUTION: This amido derivative is shown by formula I [R1 is a (substituted) 4-20C alkyl; R2 is a 1-7C alkyl; R3 is H or 2,3-dihydroxypropyl; R4 is a 2-4C alkylene] such as a compound of formula II. The compound of formula I is, for example, obtained by reacting an alcohol with epichlorohydrin in the presence of a phase transfer catalyst such as a quaternary ammonium salt or the like (e.g. tetrabutyl ammonium bromide or the like) and a base at preferably 20-80 deg.C for 1-12 hrs to form glycidyl ether, reacting the glycidyl ether with an amine derivative of formula H2N-R4 OCH3 at preferably 20-150 deg.C for 2-8 hrs to form an intermediate of formula III and reacting the resulting intermediate of formula III with an ester such as methyl propionate at preferably 15-100 deg.C for 2-8 hrs. Preferably, an external preparation contains 0.01-10 wt.% the above compound.
-
公开(公告)号:JPH11106321A
公开(公告)日:1999-04-20
申请号:JP27087497
申请日:1997-10-03
Applicant: KAO CORP
Inventor: TSUJI NAOKO , MORIWAKI SHIGERU , TAKEMA YOSHINORI , KANAZAWA SATOSHI , NISHIZAWA YOSHINORI , IMOKAWA GENJI
Abstract: PROBLEM TO BE SOLVED: To obtain a hair-growing inhibitor which shows excellent hair-growing inhibitory activity and is high in the safety by formulating a specific plant extract thereto. SOLUTION: This inhibitor contains an extract from a plant selected from ginger, hydrolyzed almond, burnet, clove, rose fruit, hawthorn, white birch and gambir in an amount of 0.0001-50 wt.%, preferably 0.001-10 wt.%, as the dry solid. The above-stated plant extract other than the hydrolyzed almond is an extract obtained by extracting crushed pieces of the above-stated plants with various solvents or by the use of extraction tools, its diluent, its concentrate or its dried powder, and the hydrolyzed almond is obtained by immersing silk fibers into a mixture of an acid or an alkali and water and/or ethanol usually at 3-100 deg.C and then removing insoluble matters.
-
公开(公告)号:JPH10324611A
公开(公告)日:1998-12-08
申请号:JP5803898
申请日:1998-03-10
Applicant: KAO CORP
Inventor: TSUJI NAOKO , MORIWAKI SHIGERU , IMOKAWA GENJI , SUZUKI YASUTO , NISHIZAWA YOSHINORI , TSUKAHARA KAZUE
IPC: A61K8/55 , A61K8/00 , A61K8/02 , A61K8/58 , A61K8/60 , A61Q17/04 , A61Q19/00 , A61Q19/08 , A61K7/00 , A61K7/42 , A61K7/48
Abstract: PROBLEM TO BE SOLVED: To obtain the subject preventing agent having an action for inhibiting a metal-dependent elastin-degrading enzyme and useful as a surgical agent by including a specific phosphonic acid derivative or its salt. SOLUTION: This preventing agent contains a phosphonic acid of formula I [R -R are each H, a (substituted) hydrocarbon group or a (substituted) sugar residue], e.g. a compound of formula II, preferably in an amount of 0-.0001-10 wt.%, especially 0.0001-5 wt.%, and, if necessary, further a UV-absorbing agent or a UV-preventing agent in an amount of 0.001-99 wt.%, especially 0.001-50 wt.%, and can prevent or improve skin-ageing phenomena such as skin wrinkles or sags accompanied by ageing as a surgical material.
-
公开(公告)号:JPH10265359A
公开(公告)日:1998-10-06
申请号:JP7169897
申请日:1997-03-25
Applicant: KAO CORP
Inventor: TSUJI NAOKO , MORIWAKI SHIGERU , IMOKAWA GENJI , SUZUKI YASUTO , NISHIZAWA YOSHINORI
IPC: A61K8/30 , A61K8/00 , A61K8/49 , A61K8/55 , A61K8/58 , A61K8/98 , A61Q1/00 , A61Q1/12 , A61Q19/00 , A61Q19/08 , A61K7/48 , A61K7/00
Abstract: PROBLEM TO BE SOLVED: To obtain a preventive for wrinkle formation, capable of preventing and improving the occurrence of wrinkle caused by aging of skin by including a metal-dependent elastin decomposing inhibitor as an active ingredient. SOLUTION: This medicine comprises a metal-dependent elastin decomposing inhibitor, especially a metal-dependent elastin decomposing inhibitor derived from a fibroblast of corium, such as a phosphonic acid derivative or a mercaptopropionamide derivative as an active ingredient. The medicine is further formulated with an ultraviolet absorber or an ultraviolet controller to preferably prepare a skin preparation for external use. The formulated amount of the metal-dependent elastin decomposing enzyme inhibitor in the case of preparing the skin preparation for external use is preferably 0.0001-5 wt.% based on the whole composition. The elastin decomposing enzyme includes one belonging to a serine protease and one belonging to a metal-dependent protease. An elastase inhibitor belonging to the metal protease has excellent controlling action on wrinkle formation.
-
公开(公告)号:JPH1095716A
公开(公告)日:1998-04-14
申请号:JP26771096
申请日:1996-09-19
Applicant: KAO CORP
Inventor: OKAMOTO YOSHIMASA , KOBAYASHI TAKESHI , IMOKAWA GENJI
Abstract: PROBLEM TO BE SOLVED: To obtain a grain hair preventive agent excellent in not only effects for prevention of generation of gray hairs and reform of the gray hairs but also safety by using a specific phosphodiesterase inhibitor as an active ingredient. SOLUTION: Among various inhibitors against phosphodiesterase (hereinafter written briefly as PDE) which is an enzyme decomposing cAMP, PDE IV type selective inhibitors [however, 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone is excluded] are used. As the PDE type selective inhibitors, compounds of the formula (R1 and R2 are each H, OH, COOH, an alkyl, an alkenyl, an alkoxy and carboxymethyloxy; R3 is H, an alkyl and an alkenyl) or their salts are preferable. Among them, rolipram, namely 4-(3-cyclopentyloxy-4- methoxyphenyl)-2-pyrrolidinone, or its salt is suitable. The inhibitors are preferably formulated in an amount of about 0.01-10wt.%, particularly about 0.05-5wt.%, based on the whole composition.
-
公开(公告)号:JPH1045613A
公开(公告)日:1998-02-17
申请号:JP21908896
申请日:1996-08-02
Applicant: KAO CORP
Inventor: KONDO HIDEHIKO , TAZAKI SHINICHI , ICHIKAWA YOSHIAKI , IMOKAWA GENJI
IPC: A61K8/96 , A61K8/00 , A61K8/97 , A61K36/00 , A61K36/07 , A61K36/18 , A61K36/23 , A61K36/75 , A61P17/00 , A61P29/00 , A61P43/00 , A61Q11/00 , A61Q19/00 , A61K35/78 , A61K7/00 , A61K7/26 , A61K7/48 , A61K35/84
Abstract: PROBLEM TO BE SOLVED: To obtain the subject inhibitor excellent in stability, safety and cost, having preventing or treating effects on atopic dermatitis, strong in effect, comprising a plant such as Ephedra sinica or its extract as an active ingredient. SOLUTION: This inhibitor comprises one or more plants selected from Ephedra sinica, Citrus aurantium, Amomumxanthioides, TAKUSYA (bulb of Alisma plantago-aquatica), Efvinga applanta, SAIKO (root of Bupleurum falcatum), cinnamon bark and Tilia japonica or its extract as an active ingredient. For example, the plant is used as or dried, ground and used. The ground dried material is subjected to an extraction treatment with water and/or an aqueous alcohol at 3-l00 deg.C, usually 3-70 deg.C. Preferably, the extract is used. A dose is preferably 0.1-2,000mg as an active ingredient per adult daily.
-
公开(公告)号:JPH09124500A
公开(公告)日:1997-05-13
申请号:JP28340695
申请日:1995-10-31
Applicant: KAO CORP
Inventor: TEZUKA YOKO , YOROZU HIDENORI , TAKAGI YUTAKA , HIGUCHI KAZUHIKO , IMOKAWA GENJI , YADA YUKIHIRO
IPC: A61K8/96 , A61K8/00 , A61K8/68 , A61K8/97 , A61K8/98 , A61K35/32 , A61K35/55 , A61K36/00 , A61K36/18 , A61K36/25 , A61K36/258 , A61K36/47 , A61K36/65 , A61K36/71 , A61K36/74 , A61K125/00 , A61K135/00 , A61P17/00 , A61Q19/00 , A61K35/78 , A61K7/00 , A61K7/48
Abstract: PROBLEM TO BE SOLVED: To obtain the subject agent useful for treating dermal symptoms in an atopic disease, comprising a specific crude medicine having inhibitory action on physiological activities of sphingosylphosphorylcholine as an active ingredient. SOLUTION: This therapeutic agent for atopic dermatitis comprises one or more of essences of crude medicines selected from Paenoia suffruticosa Andrews, Panax ginseng C.A.Meyer, Cervus(Cervus) elaphus L. var. xanthopygus Milne-Edwards, Mallotus japonicus (Thunb. ex L.f.) Muell.Arg., Uncaria sinensis (OLIV.) Havil and Civet cat as an active ingredient. The essence of the crude medicine suppresses rise in calcium ion concentration in a cell by sphingosylphosphorylcholine. The content of the essence in the therapeutic agent is 0.00001 to 5wt.% calculated as a dried solid content.
-
公开(公告)号:JPH0840840A
公开(公告)日:1996-02-13
申请号:JP17639894
申请日:1994-07-28
Applicant: KAO CORP
Inventor: KOBAYASHI HISATAKA , KUDOU MICHIMASA , IMOKAWA GENJI , OKUDA MINEHIRO
IPC: A61K8/00 , A61K8/40 , A61K8/41 , A61K8/49 , A61K31/13 , A61K31/14 , A61K31/44 , A61P17/00 , A61P31/04 , A61Q5/00 , A61Q5/02 , A61K7/06
Abstract: PURPOSE:To obtain a composition for external use in the scalp capable of manifesting ultrahigh suppressing effects on dandruff and pruritus and further excellent in persistence of the effects by using an antimicrobial agent used for the purpose of preventing the dandruff and pruritus with a keratinization improving agent. CONSTITUTION:This composition for external use in the scalp is obtained by using an antimicrobial agent which is a preventing agent for dandruff and pruritus and a keratinization improving agent comprising an amine derivative of formula I [R is a 4-40C straight-chain, branched chain or cyclic saturated or unsaturated hydrocarbon; R to R are each H or a 1-10C hydrocarbon (which can be substituted with OH)] or its acid addition salt in combination. An antimicrobial agent selected from a polyvalent metallic salt of 2- mercaptopyridine N-oxide, a 1-hydroxy-2-pyrrolidone derivative of formula II (R is an alkyl, an alkenyl, a cycloalkyl, etc.; R is H, an alkyl, an alkenyl, etc.; X is an organic salt group, a cation, etc.), 2,2'-dithio-bis-(pyridine N-oxide) of formula III and a benzalkonium salt of formula IV (R is a hydrocarbon; Y is an anion residue such as a phosphoric ester) is especially preferred as the antimicrobial agent.
-
公开(公告)号:JPH07330743A
公开(公告)日:1995-12-19
申请号:JP12874294
申请日:1994-06-10
Applicant: KAO CORP
Inventor: HOSHINO TADAHIDE , SUGIYAMA MITSURU , KAWAMATA AKIRA , JOKURA HIROKO , IMOKAWA GENJI
Abstract: PURPOSE:To obtain the subject new compound useful for a cosmetic, showing excellent ultraviolet light absorbing action in a wide wavelength region, having excellent stability, light stability and oil solubility. CONSTITUTION:A compound of formula I (R and R are each a hydrocarbon). The compound is obtained by condensing 2,4,6-tri(4-formylphenoxy)-striazine of formula II with a malonate derivative of formula III in the presence of a catalyst (e.g. piperidine-acetic acid) in a solvent (e.g. benzene). Since the compound of formula I absorbs ultraviolet light in a wide wavelength region from UV-A to UV-B and is hardly decomposed with an amount of sunlight to which human is daily exposed, it hardly has an influence on skin caused by a decomposition product, etc. It has no problem in terms of stability, toxicity, irritation, etc. The compound of formula I has excellent affinity for other cosmetic bases and an ultraviolet light absorber and a cosmetic containing the compound of formula I show an excellent feeling of use and durability of ultraviolet light screening action.
-
-
-
-
-
-
-
-
-